> top > docs > PMC:7321036 > spans > 3555-4739 > annotations

PMC:7321036 / 3555-4739 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T106 20-30 SP_7 denotes SARS-CoV-2
T107 78-86 SP_10 denotes SARS-CoV
T108 88-98 SP_7 denotes SARS-CoV-2
T109 110-121 NCBITaxon:11118 denotes coronavirus
T110 198-206 SP_10 denotes SARS-CoV
T111 208-218 SP_7 denotes SARS-CoV-2
T112 479-489 SP_7 denotes SARS-CoV-2
T113 614-622 SP_7 denotes COVID-19
T114 647-655 SP_7 denotes COVID-19
T115 728-738 DG_28 denotes remdesivir
T116 833-841 SP_7 denotes COVID-19
T117 852-856 CHEBI:33290;CHEBI:33290 denotes Food
T118 861-865 CHEBI:23888;CHEBI:23888 denotes Drug
T119 942-952 DG_28 denotes remdesivir
T120 983-991 SP_7 denotes COVID-19
T121 1046-1056 SP_7 denotes SARS-CoV-2
T122 1069-1075 CHEBI:52217;CHEBI:52217 denotes agents
T123 1166-1174 SP_7 denotes COVID-19

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T2 177-182 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T32 20-28 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T33 78-86 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T34 88-96 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T35 198-206 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T36 208-216 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T37 219-228 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T38 479-487 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T39 614-622 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 647-655 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 678-687 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T42 833-841 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 983-991 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 1046-1054 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T45 1166-1174 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T85317 102-103 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T59147 740-741 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T17 728-738 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T18 757-772 Chemical denotes antiviral agent http://purl.obolibrary.org/obo/CHEBI_22587
T19 942-952 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
110 20-30 Species denotes SARS-CoV-2 Tax:2697049
111 78-86 Species denotes SARS-CoV Tax:694009
112 88-98 Species denotes SARS-CoV-2 Tax:2697049
113 104-121 Species denotes novel coronavirus Tax:2697049
114 198-206 Species denotes SARS-CoV Tax:694009
115 479-489 Species denotes SARS-CoV-2 Tax:2697049
116 960-968 Species denotes patients Tax:9606
117 1046-1056 Species denotes SARS-CoV-2 Tax:2697049
118 1120-1130 Species denotes outpatient Tax:9606
119 728-738 Chemical denotes remdesivir MESH:C000606551
120 942-952 Chemical denotes remdesivir MESH:C000606551
121 208-228 Disease denotes SARS-CoV-2 infection MESH:C000657245
122 614-622 Disease denotes COVID-19 MESH:C000657245
123 647-655 Disease denotes COVID-19 MESH:C000657245
124 678-687 Disease denotes infection MESH:D007239
125 833-841 Disease denotes COVID-19 MESH:C000657245
126 983-991 Disease denotes COVID-19 MESH:C000657245
127 1166-1174 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T25 0-190 Sentence denotes Although much about SARS-CoV-2 biology can be inferred based on similarity to SARS-CoV, SARS-CoV-2 is a novel coronavirus with unique properties that contribute to its pandemic-scale spread.
T26 191-413 Sentence denotes Unlike SARS-CoV, SARS-CoV-2 infection is commonly asymptomatic, particularly in the younger population (Guan et al., 2020), and contagious prior to symptom onset (Rothe et al., 2020; Peiris et al., 2003; Bai et al., 2020).
T27 414-623 Sentence denotes These characteristics contribute to the difficulty of containing SARS-CoV-2 spread through public health strategies and amplify the need to develop vaccines and therapies to protect against and treat COVID-19.
T28 624-719 Sentence denotes Clinical management of COVID-19 is largely limited to infection prevention and supportive care.
T29 720-908 Sentence denotes So far, remdesivir, a broad-spectrum antiviral agent, is the only medication approved for emergency use to treat COVID-19 by the US Food and Drug Administration (FDA) (Grein et al., 2020).
T30 909-1184 Sentence denotes Although the evidence supporting remdesivir use in patients with advanced COVID-19 is promising, there remains an urgent need for potent SARS-CoV-2 therapeutic agents, especially those that could be given in an outpatient setting, to effectively combat the COVID-19 pandemic.

2_test

Id Subject Object Predicate Lexical cue
32645325-32109013-20773035 308-312 32109013 denotes 2020
32645325-32003551-20773036 368-372 32003551 denotes 2020
32645325-14681510-20773037 389-393 14681510 denotes 2003
32645325-32083643-20773038 407-411 32083643 denotes 2020
32645325-32275812-20773039 902-906 32275812 denotes 2020